Business Services Industry
Japan Tobacco, GlaxoSmithKline Conclude Licensing Agreement for New
JCNN News Summaries - Japan Corporate News Network, Apr 20, 2006 by Aki Tsukioka
Tokyo, Apr 20, 2006 - (JCN) - Japan Tobacco (JT) has signed a licensing agreement with GlaxoSmithKline (GSK) for a candidate compound developed by JT.
Under the agreement, GSK will receive the worldwide exclusive right to develop and market the compound while JT retains co- promotion rights in Japan. In addition, JT will receive an upfront payment, milestone payments for development and royalties on future sales from GSK.
The new compound, which is currently in preclinical trials in Japan, has a property that inhibits the activity of MAPK/ ERK kinase (MEK), a kind of enzyme involved in cell proliferation.
JT expects the applications of the new compound to include treatment for cancer and inflammation.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Most Popular Business Publications
Content provided in partnership with
